generic drug prices

Why Health Systems Are Making Their Own Generics
Why Health Systems Are Making Their Own GenericsOver 450 hospitals have joined together over frustrations about drug prices and shortages.
Retailers and PBMs Laud Generic/Biosimilar Savings
Retailers and PBMs Laud Generic/Biosimilar SavingsSavings from generic and biosimilar drugs are making PBMs and pharmacies, as well as patients, happy.
Can costs be contained?There’s a lot of blame to go around when it comes to why drug costs are rising in dermatology. We’ll let the research do the finger pointing.
How three hospitals are countering rising drug prices
How three hospitals are countering rising drug pricesRising drug costs are a big problem for all healthcare systems in the U.S. Here’s how three hospitals are addressing the problem.
Soaring drug costs leave derms, patients scramblingThe costs of popular drugs—even generics—in dermatology are soaring, leaving patients scrambling for coverage or financial assistance and dermatologists spending precious hours on prior authorizations, drug appeals and reviews. In this first of a five-part series, experts and patients help define the problem.
Global generics drug market to grow 10% annuallyPatents expire, competition rises, and outsourcing expands.
How Walmart plans to save on genericsWalmart has decided to put all its eggs in a really big basket.
Are laws, regs pricing consumers out of generic drugs?A new study by National Center for Policy Analysis (NCPA) finds that generic drugs are the best bargain in the healthcare system—but that may change if recent price hikes continue.
The Honest Apothecary: "What can we do about skyrocketing generic drug prices?"First of all, take a tip from The Hitchhiker's Guide: Don't panic.
Biosimilars’ savings could be lower than predictedWhile biosimilars’ savings will not reach the historically high level achieved for small-molecule generic drugs, the impact on the healthcare industry will still be significant, according to a new report.